Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: INmune Bio Inc. INMB

MissionIRNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) Releases Q2 2019 Financial Results, Provides Shareholder Update

Posted on August 12, 2019 by MissionIR

INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced its financial results for the second quarter ended June 30, 2019 and also provided a year-to-date … Continue reading →

Posted in INmune Bio Inc. INMB, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) Names Biotechnology Executive as New Board Member

Posted on August 8, 2019 by MissionIR

INmune Bio (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced that Edgardo “Ed” Baracchini, Ph.D., has joined its board of directors. Per the update, Dr. Baracchini’s impressive … Continue reading →

Posted in INmune Bio Inc. INMB, MissionIRNewsBreaks | Leave a comment

INmune Bio Inc. (NASDAQ: INMB) Planning Phase II Trial of INB03 as Part of Combination Immunotherapy for Cancer Patients

Posted on August 7, 2019 by MissionIR

INmune Bio is currently attending the Cambridge Healthcare Institute’s 7th Annual Immuno-Oncology Summit in Boston Co-founder and CEO Dr. RJ Tesi is presenting positive preliminary data on INB03, which is being developed as part of a combination immunotherapy to potentially … Continue reading →

Posted in INmune Bio Inc. INMB | Leave a comment

MissionIRNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) Reports Positive Preliminary Data from Phase I Clinical Trial of INB03

Posted on August 5, 2019 by MissionIR

INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today reported positive preliminary data during a presentation at Cambridge Healthtech Institute’s Seventh Annual Immuno-Oncology Summit in Boston. … Continue reading →

Posted in INmune Bio Inc. INMB, MissionIRNewsBreaks | Leave a comment

INmune Bio Inc. (NASDAQ: INMB) Presents Cancer Treatment Immunotherapy at Congress of International Drug Discovery Science & Technology

Posted on August 2, 2019 by MissionIR

INmune Bio attended the 17th Annual Congress of International Drug Discovery Science & Technology in Japan Co-founder and CEO R.J. Tesi and Director of Neuroscience C.J. Barnum both participated in talks about the role of immunotherapy in the treatment of … Continue reading →

Posted in INmune Bio Inc. INMB | Leave a comment

MissionIRNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) Co-Founder and CEO to Present at Cambridge Healthcare Institute’s Seventh Annual Immuno-Oncology Summit

Posted on August 1, 2019 by MissionIR

INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, this morning announced that its Co-Founder and CEO RJ Tesi, M.D. will present at the Cambridge Healthcare Institute’s … Continue reading →

Posted in INmune Bio Inc. INMB, MissionIRNewsBreaks | Leave a comment

Research Highlights Virtues of INmune Bio Inc.’s (NASDAQ: INMB) Strategy in Fighting Cancer with Body’s Own Natural Cells

Posted on July 29, 2019 by MissionIR

California-based INmune Bio is developing therapies to battle cancers and Alzheimer’s disease by more effectively engaging the body’s own natural defenses Research published in a peer-reviewed scientific journal shows a mechanism by which scientists can track and strategize natural killer … Continue reading →

Posted in INmune Bio Inc. INMB | Leave a comment

MissionIRNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) to Present at 17th Annual Congress of International Drug Discovery Science & Technology 2019

Posted on July 25, 2019 by MissionIR

INmune Bio (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, this morning announced that its Director of Neuroscience, C.J. Barnum, and Co-Founder and CEO, R.J. Tesi, M.D., will present … Continue reading →

Posted in INmune Bio Inc. INMB, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – INmune Bio Inc.’s (NASDAQ: INMB) Innovative Drug Candidate Targets Neuroinflammation to Treat Alzheimer’s Disease

Posted on July 19, 2019 by MissionIR

INmune Bio (NASDAQ: INMB) is an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, such as Alzheimer’s disease (“AD”). A recent article discussing the company reads, “An association between inflammation and Alzheimer’s … Continue reading →

Posted in INmune Bio Inc. INMB, MissionIRNewsBreaks | Leave a comment

TNF Inhibitors Such as INmune Bio Inc.’s (NASDAQ: INMB) XPro1595 May Reduce the Risk of Alzheimer’s Development, Report Suggests

Posted on July 17, 2019 by MissionIR

Research indicates that anti-inflammatory medications have the power to prevent the onset and control the symptoms of Alzheimer’s disease The link between inflammatory processes and Alzheimer’s has long been established; companies like INmune Bio are working to further the research … Continue reading →

Posted in INmune Bio Inc. INMB | Leave a comment